Jordan Westburg's season-ending elbow surgery is a setback for the Orioles and the player himself. With a history of injuries, Westburg's career has been marred by setbacks, and this latest development is a stark reminder of the challenges he faces. The partial tear of his ulnar collateral ligament, diagnosed in February, led to a non-surgical approach initially, but continued discomfort forced the team's hand. The decision to undergo surgery is a common one for players, as the recovery timeline is often lengthy, and the team aims to explore alternatives first. However, the best-case scenario of a quick return in 2026 is now out of reach.
Westburg's injury history is a concern, with a hand fracture in 2024 and subsequent hamstring and ankle strains in 2025. His service time will cross three years, qualifying him for arbitration through 2029. The Orioles' infield depth is already stretched thin, with Jackson Holliday, Dylan Beavers, Ryan Mountcastle, and Heston Kjerstad on the injured list. The team's record of 20-24 is a testament to the impact of these injuries, and the need for infield help is evident. With Westburg out for the season, the Orioles must look to other players to step up and fill the void. The trade deadline looms, and the team may seek to bolster their infield options to stay competitive in the American League.
This situation highlights the delicate balance between player health and team performance. While the Orioles have managed to stay in the playoff race, the loss of Westburg is a significant blow. The team's ability to adapt and find solutions will be crucial in the coming months. The future of the Orioles and Westburg's career hangs in the balance, as the team navigates the challenges of injuries and the pursuit of success.
